What are the major opportunities in the non-alcoholic steatohepatitis treatment market? What are the strategies for the non-alcoholic steatohepatitis treatment market?

For detailed insights on the major opportunities and strategies in the non-alcoholic steatohepatitis treatment market, Read More

How does the non-alcoholic steatohepatitis treatment market relate to the overall economy and other similar markets?

For detailed insights on non-alcoholic steatohepatitis treatment market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the non-alcoholic steatohepatitis treatment market growth? SWOT analysis of the non-alcoholic steatohepatitis treatment market.

For detailed insights on the key dynamics influencing the non-alcoholic steatohepatitis treatment market growth and SWOT analysis of the non-alcoholic steatohepatitis treatment industry, Read More

Non-Alcoholic Steatohepatitis Treatment Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Non-Alcoholic Steatohepatitis Treatment Market Report 2026

Name: Non-Alcoholic Steatohepatitis Treatment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types), By Test Type (Blood Tests, Liver Biopsy, Imaging Procedures), By End User (Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Alcoholic Steatohepatitis Treatment Market Overview

• Non-Alcoholic Steatohepatitis Treatment market size has reached to $3.57 billion in 2025

• Expected to grow to $18.97 billion in 2030 at a compound annual growth rate (CAGR) of 39.7%

• Growth Driver: Insulin Resistance Surge Fueling Growth In The Non-Alcoholic Steatohepatitis Treatment Market

• Market Trend: Pioneering Endogenous Hormones In Non-Alcoholic Steatohepatitis Treatment Market

• North America was the largest region in 2025.

What Is Covered Under Non-Alcoholic Steatohepatitis Treatment Market?

The non-alcoholic steatohepatitis treatment refers to a treatment used in steatohepatitis by maintaining a healthy diet, control of blood sugar, loss of body weight and fat. It is a treatment type for liver disease in which people who drink little, or no alcohol develop fatty livers. This causes liver cell destruction and inflammation, which can lead to cirrhosis.

The main drug of non-alcoholic steatohepatitis treatment are vitamin E and pioglitazone, ocaliva, elafibranor, selonsertib and cenicriviroc, obeticholic acid, and others. Vitamin E and pioglitazone in the non-alcoholic steatohepatitis treatment refers to an important fat-soluble nutrient medication needed for immune health. It is used to improve NASH by reducing oxidative stress of hepatocytes and reduce liver injury and inflammation, while pioglitazone can improve insulin sensitivity and high blood sugar levels caused by type 2 diabetes. The treatment test includes blood tests, liver biopsy, and imaging procedures, performed in hospital pharmacies, retail and specialty pharmacies, and others.

Non-Alcoholic Steatohepatitis Treatment Market Global Report 2026 Market Report bar graph

What Is The Non-Alcoholic Steatohepatitis Treatment Market Size and Share 2026?

The non-alcoholic steatohepatitis treatment market size has grown exponentially in recent years. It will grow from $3.57 billion in 2025 to $4.98 billion in 2026 at a compound annual growth rate (CAGR) of 39.6%. The growth in the historic period can be attributed to rising prevalence of obesity, increasing incidence of type 2 diabetes, high consumption of processed foods, lack of awareness about liver health, limited treatment options for early-stage nash.

What Is The Non-Alcoholic Steatohepatitis Treatment Market Growth Forecast?

The non-alcoholic steatohepatitis treatment market size is expected to see exponential growth in the next few years. It will grow to $18.97 billion in 2030 at a compound annual growth rate (CAGR) of 39.7%. The growth in the forecast period can be attributed to advancements in precision medicine, development of novel nash drugs, adoption of digital health monitoring tools, government initiatives for liver disease prevention, increasing investment in liver disease research. Major trends in the forecast period include personalized lifestyle & diet management, non-invasive diagnostic advancements, fatty liver disease awareness programs, home-based liver health monitoring, novel pharmacological agents development.

Book your 30 minutes free consultation with our research experts

Global Non-Alcoholic Steatohepatitis Treatment Market Segmentation

1) By Drug Type: Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types

2) By Test Type: Blood Tests, Liver Biopsy, Imaging Procedures

3) By End User: Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users

Subsegments:

1) By Vitamin E And Pioglitazone: Vitamin E Supplements, Pioglitazone-Based Formulations.

2) By Ocaliva: Ocaliva (Obeticholic Acid) For NASH

3) By Elafibranor: Elafibranor Monotherapy, Elafibranor Combination Therapy

4) By Selonsertib And Cenicriviroc: Selonsertib Formulations, Cenicriviroc Formulations

5) By Obeticholic Acid: Immediate-Release Obeticholic Acid, Extended-Release Obeticholic Acid

6) By Other Drug Types: Novel Agents In Clinical Trials, Combination Therapies

What Is The Driver Of The Non-Alcoholic Steatohepatitis Treatment Market?

An increased prevalence of insulin resistance has propelled the growth of the non-alcoholic steatohepatitis treatment market going forward. Insulin resistance occurs when muscles, fat, and liver cells do not respond adequately to insulin and cannot easily absorb glucose from the blood, causing high blood sugar. These are linked to an unhealthy lifestyle, excessive sugar consumption, and genetics. The use of insulin resistance has multiplied due to increased diabetes and other liver-related issues, which are treated with non-alcoholic steatohepatitis treatment. For instance, July 2025, according to PubMed, a US-based free biomedical literature database maintained by the U.S. National Library of Medicine, reported that the prevalence rates of general obesity, abdominal obesity, severe obesity, and insulin resistance increased significantly, with rates increasing from 34.9% to 41.4%, 62.5% to 67.0%, 5.2% to 11.5%, and 22.5% to 30.2%, respectively. Therefore, an increase in the prevalence of insulin resistance due to multiple liver and diabetes diseases will drive the non-alcoholic steatohepatitis treatment industry.

Key Players In The Global Non-Alcoholic Steatohepatitis Treatment Market

Major companies operating in the non-alcoholic steatohepatitis treatment market are AstraZeneca PLC, Galmed Pharmaceuticals Ltd., Genfit S.A., Zydus Cadila Healthcare Limited, Bristol-Myers Squibb Company, Gilead Sciences Inc., Novo Nordisk A/S, Inventiva Pharma SA, NGM Biopharmaceuticals Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals Corporation, Intercept Pharmaceuticals Inc., Cirius Therapeutics Inc., Viking Therapeutics Inc., Eli Lilly and Company, Terns Pharmaceuticals Inc., AbbVie Inc., Johnson & Johnson Private Limited, Sanofi S.A., F. Hoffmann-La Roche Ltd., C.H. Boehringer Sohn AG & Co. KG

Global Non-Alcoholic Steatohepatitis Treatment Market Trends and Insights

Major companies operating in the non-alcoholic steatohepatitis treatment market are developing innovative products such as endogenous hormones to meet larger customer bases, more sales, and increase revenue. Endogenous hormones are naturally occurring substances produced within the body by various glands, tissues, or organs, and they play crucial roles in regulating physiological processes. For instance, in September 2023, 89bio Inc., a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has given Breakthrough Therapy Designation (BTD) for Pegozafermin in individuals diagnosed with nonalcoholic steatohepatitis (NASH). Pegozafermin stands out as a distinctive product due to its engineered glycoPEGylated analog of fibroblast growth factor 21. This specifically designed formulation is under development for addressing non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). What makes Pegozafermin unique is its utilization of a specialized glycoPEGylated technology, ensuring an extended half-life while preserving its potency. This innovative approach enhances the product's effectiveness in modulating key factors related to lipid metabolism, NASH, and hypertriglyceridemia, including triglyceride reduction, glycemic control, steatosis, inflammation, and fibrosis.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Treatment Market?

In September 2023, Kriya Therapeutics, a US-based biotechnology company focused on gene therapy for metabolic and neurodegenerative diseases, acquired Tramontane Therapeutics for an undisclosed amount. With this acquisition, Kriya aims to strengthen its NASH treatment pipeline by adding a one-time gene therapy program targeting Fibroblast Growth Factor 21, enhancing its technological capabilities in metabolic-liver disease therapeutics. Tramontane Therapeutics is a Spain-based biotechnology company developing gene therapy programs for metabolic and neurodegenerative diseases, including a lead candidate for non-alcoholic steatohepatitis (NASH) using AAV-mediated FGF21 expression.

Regional Insights

North America was the largest region in the non-alcoholic steatohepatitis treatment market share in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Alcoholic Steatohepatitis Treatment Market?

The non-alcoholic steatohepatitis treatment market includes revenues earned by entities by providing services such as liver related ?medical diagnosis and tests, fatty liver management and treatment, abdominal ultrasound. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Alcoholic Steatohepatitis Treatment Market Report 2026?

The non-alcoholic steatohepatitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-alcoholic steatohepatitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Non-Alcoholic Steatohepatitis Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.98 billion
Revenue Forecast In 2035	$18.97 billion
Growth Rate	CAGR of 39.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Test Type, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AstraZeneca PLC, Galmed Pharmaceuticals Ltd., Genfit S.A., Zydus Cadila Healthcare Limited, Bristol-Myers Squibb Company, Gilead Sciences Inc., Novo Nordisk A/S, Inventiva Pharma SA, NGM Biopharmaceuticals Inc., Galectin Therapeutics Inc., Madrigal Pharm
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Non-Alcoholic Steatohepatitis Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Non-Alcoholic Steatohepatitis Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Non-Alcoholic Steatohepatitis Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Non-Alcoholic Steatohepatitis Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Personalized Lifestyle & Diet Management

4.2.2 Non-Invasive Diagnostic Advancements

4.2.3 Fatty Liver Disease Awareness Programs

4.2.4 Home-Based Liver Health Monitoring

4.2.5 Novel Pharmacological Agents Development

5. Non-Alcoholic Steatohepatitis Treatment Market Analysis Of End Use Industries

5.1 Hospital Pharmacies

5.2 Retail Pharmacies

5.3 Specialty Pharmacies

5.4 Diagnostic Centers

5.5 Research Institutions

6. Non-Alcoholic Steatohepatitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Alcoholic Steatohepatitis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-Alcoholic Steatohepatitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Non-Alcoholic Steatohepatitis Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Non-Alcoholic Steatohepatitis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Alcoholic Steatohepatitis Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Alcoholic Steatohepatitis Treatment Market Segmentation

9.1. Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types

9.2. Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood Tests, Liver Biopsy, Imaging Procedures

9.3. Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail And Specialty Pharmacies, Other End Users

9.4. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Vitamin E And Pioglitazone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vitamin E Supplements, Pioglitazone-Based Formulations

9.5. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Ocaliva, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ocaliva (Obeticholic Acid) For NASH

9.6. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Elafibranor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Elafibranor Monotherapy, Elafibranor Combination Therapy

9.7. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Selonsertib And Cenicriviroc, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Selonsertib Formulations, Cenicriviroc Formulations

9.8. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Obeticholic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immediate-Release Obeticholic Acid, Extended-Release Obeticholic Acid

9.9. Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Novel Agents In Clinical Trials, Combination Therapies

10. Non-Alcoholic Steatohepatitis Treatment Market Regional And Country Analysis

10.1. Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market

11.1. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Alcoholic Steatohepatitis Treatment Market

12.1. China Non-Alcoholic Steatohepatitis Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Alcoholic Steatohepatitis Treatment Market

13.1. India Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Alcoholic Steatohepatitis Treatment Market

14.1. Japan Non-Alcoholic Steatohepatitis Treatment Market Overview

14.2. Japan Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Alcoholic Steatohepatitis Treatment Market

15.1. Australia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Alcoholic Steatohepatitis Treatment Market

16.1. Indonesia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Alcoholic Steatohepatitis Treatment Market

17.1. South Korea Non-Alcoholic Steatohepatitis Treatment Market Overview

17.2. South Korea Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Alcoholic Steatohepatitis Treatment Market

18.1. Taiwan Non-Alcoholic Steatohepatitis Treatment Market Overview

18.2. Taiwan Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Alcoholic Steatohepatitis Treatment Market

19.1. South East Asia Non-Alcoholic Steatohepatitis Treatment Market Overview

19.2. South East Asia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Alcoholic Steatohepatitis Treatment Market

20.1. Western Europe Non-Alcoholic Steatohepatitis Treatment Market Overview

20.2. Western Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Alcoholic Steatohepatitis Treatment Market

21.1. UK Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Alcoholic Steatohepatitis Treatment Market

22.1. Germany Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Alcoholic Steatohepatitis Treatment Market

23.1. France Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Alcoholic Steatohepatitis Treatment Market

24.1. Italy Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Alcoholic Steatohepatitis Treatment Market

25.1. Spain Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market

26.1. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market Overview

26.2. Eastern Europe Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Alcoholic Steatohepatitis Treatment Market

27.1. Russia Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Alcoholic Steatohepatitis Treatment Market

28.1. North America Non-Alcoholic Steatohepatitis Treatment Market Overview

28.2. North America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Alcoholic Steatohepatitis Treatment Market

29.1. USA Non-Alcoholic Steatohepatitis Treatment Market Overview

29.2. USA Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Alcoholic Steatohepatitis Treatment Market

30.1. Canada Non-Alcoholic Steatohepatitis Treatment Market Overview

30.2. Canada Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Alcoholic Steatohepatitis Treatment Market

31.1. South America Non-Alcoholic Steatohepatitis Treatment Market Overview

31.2. South America Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Alcoholic Steatohepatitis Treatment Market

32.1. Brazil Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Alcoholic Steatohepatitis Treatment Market

33.1. Middle East Non-Alcoholic Steatohepatitis Treatment Market Overview

33.2. Middle East Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Alcoholic Steatohepatitis Treatment Market

34.1. Africa Non-Alcoholic Steatohepatitis Treatment Market Overview

34.2. Africa Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Segmentation By Test Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Alcoholic Steatohepatitis Treatment Market Regulatory and Investment Landscape

36. Non-Alcoholic Steatohepatitis Treatment Market Competitive Landscape And Company Profiles

36.1. Non-Alcoholic Steatohepatitis Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Non-Alcoholic Steatohepatitis Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Non-Alcoholic Steatohepatitis Treatment Market Company Profiles

36.3.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Galmed Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Genfit S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Zydus Cadila Healthcare Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Non-Alcoholic Steatohepatitis Treatment Market Other Major And Innovative Companies

Gilead Sciences Inc., Novo Nordisk A/S, Inventiva Pharma SA, NGM Biopharmaceuticals Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals Corporation, Intercept Pharmaceuticals Inc., Cirius Therapeutics Inc., Viking Therapeutics Inc., Eli Lilly and Company, Terns Pharmaceuticals Inc., AbbVie Inc., Johnson & Johnson Private Limited, Sanofi S.A., F. Hoffmann-La Roche Ltd.

38. Global Non-Alcoholic Steatohepatitis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Treatment Market

40. Non-Alcoholic Steatohepatitis Treatment Market High Potential Countries, Segments and Strategies

40.1 Non-Alcoholic Steatohepatitis Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Non-Alcoholic Steatohepatitis Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Non-Alcoholic Steatohepatitis Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Non-Alcoholic Steatohepatitis Treatment Market, Overview Of Key Products - Product Examples

Table 2: Global Non-Alcoholic Steatohepatitis Treatment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Non-Alcoholic Steatohepatitis Treatment Market, Supply Chain Analysis

Table 4: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Raw Material Providers

Table 5: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Resource Providers

Table 6: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Manufacturers (Suppliers)

Table 7: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Distributors And Channel Partners

Table 8: Global Non-Alcoholic Steatohepatitis Treatment Market, Key Technologies & Future Trends

Table 9: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Trends

Table 10: Global Non-Alcoholic Steatohepatitis Treatment Market, Major End Users

Table 11: Global Non-Alcoholic Steatohepatitis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Non-Alcoholic Steatohepatitis Treatment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Non-Alcoholic Steatohepatitis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Non-Alcoholic Steatohepatitis Treatment Market - TAM, US$ Billion, 2025

Table 15: Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Vitamin E And Pioglitazone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Ocaliva, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Elafibranor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Selonsertib And Cenicriviroc, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Obeticholic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Non-Alcoholic Steatohepatitis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Non-Alcoholic Steatohepatitis Treatment Market - Company Scoring Matrix

Table 100: AstraZeneca PLC Financial Performance

Table 101: Galmed Pharmaceuticals Ltd. Financial Performance

Table 102: Genfit S.A. Financial Performance

Table 103: Zydus Cadila Healthcare Limited Financial Performance

Table 104: Bristol-Myers Squibb Company Financial Performance

Table 105: Global Non-Alcoholic Steatohepatitis Treatment Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Non-Alcoholic Steatohepatitis Treatment Market, Competitive Dashboard

Table 107: Global Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 109: Global, Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Table 110: Global, Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Non-Alcoholic Steatohepatitis Treatment Market, Overview Of Key Products - Product Examples

Figure 2: Global Non-Alcoholic Steatohepatitis Treatment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Non-Alcoholic Steatohepatitis Treatment Market, Supply Chain Analysis

Figure 4: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Raw Material Providers

Figure 5: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Resource Providers

Figure 6: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Manufacturers (Suppliers)

Figure 7: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Distributors And Channel Partners

Figure 8: Global Non-Alcoholic Steatohepatitis Treatment Market, Key Technologies & Future Trends

Figure 9: Global Non-Alcoholic Steatohepatitis Treatment Market, Major Trends

Figure 10: Global Non-Alcoholic Steatohepatitis Treatment Market, Major End Users

Figure 11: Global Non-Alcoholic Steatohepatitis Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Non-Alcoholic Steatohepatitis Treatment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Non-Alcoholic Steatohepatitis Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Non-Alcoholic Steatohepatitis Treatment Market - TAM, US$ Billion, 2025

Figure 15: Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Vitamin E And Pioglitazone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Ocaliva, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Elafibranor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Selonsertib And Cenicriviroc, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Obeticholic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Non-Alcoholic Steatohepatitis Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Non-Alcoholic Steatohepatitis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Non-Alcoholic Steatohepatitis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Non-Alcoholic Steatohepatitis Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Non-Alcoholic Steatohepatitis Treatment Market - Company Scoring Matrix

Figure 100: AstraZeneca PLC Financial Performance

Figure 101: Galmed Pharmaceuticals Ltd. Financial Performance

Figure 102: Genfit S.A. Financial Performance

Figure 103: Zydus Cadila Healthcare Limited Financial Performance

Figure 104: Bristol-Myers Squibb Company Financial Performance

Figure 105: Global Non-Alcoholic Steatohepatitis Treatment Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Non-Alcoholic Steatohepatitis Treatment Market, Competitive Dashboard

Figure 107: Global Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 109: Global, Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Figure 110: Global, Non-Alcoholic Steatohepatitis Treatment Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Non-Alcoholic Steatohepatitis Treatment Market Report 2026 - Global Outlook – By Drug Type (Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types), By Test Ty...

Non-Alcoholic Steatohepatitis Biomarkers Market Report 2026 - Global Outlook – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Technology (Enzym...

Fatty Liver Treatment Market Report 2026 - Global Outlook – By Treatment Type (Anti-Viral Drugs, Chemotherapy Drugs, Targeted Therapy, Anti-Fibrotic Drugs), By Disease Type (Hepatitis, Liver Cancer, Non-Alcoholic Fatty L...

Alcoholic Hepatitis Treatment Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Supportive And Nutritional Therapy), By Route Of Administration (Oral, Injectable), By Severity Of Disease (Mild Alcoho...

Liver Diseases Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment (Antiviral, Chemotherapy, Immunosuppressive A...

Hepatorenal Syndrome Treatment Market Report 2026 - Global Outlook – By Type (Type 1 Hepatorenal Syndrome, Type 2 Hepatorenal Syndrome), By Treatment (Therapeutics, Surgical Treatment), By End-User (Hospitals And Clinics...

Inflammatory Bowel Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Cro...

Frequently Asked Questions

How big is the Non-Alcoholic Steatohepatitis Treatment Market?

The Non-Alcoholic Steatohepatitis Treatment market was valued at $3.57 billion in 2025, increased to $4.98 billion in 2026, and is projected to reach $18.97 billion by 2030.

What is the Non-Alcoholic Steatohepatitis Treatment market growth?

The global Non-Alcoholic Steatohepatitis Treatment market is expected to grow at a CAGR of 39.7% from 2026 to 2035 to reach $18.97 billion by 2035.

Who are the key players in Non-Alcoholic Steatohepatitis Treatment market?

Some Key Players in the Non-Alcoholic Steatohepatitis Treatment market Include, AstraZeneca PLC, Galmed Pharmaceuticals Ltd., Genfit S.A., Zydus Cadila Healthcare Limited, Bristol-Myers Squibb Company, Gilead Sciences Inc., Novo Nordisk A/S, Inventiva Pharma SA, NGM Biopharmaceuticals Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals Corporation, Intercept Pharmaceuticals Inc., Cirius Therapeutics Inc., Viking Therapeutics Inc., Eli Lilly and Company, Terns Pharmaceuticals Inc., AbbVie Inc., Johnson & Johnson Private Limited, Sanofi S.A., F. Hoffmann-La Roche Ltd., C.H. Boehringer Sohn AG & Co. KG .

What is the anticipated growth trend for the Non-Alcoholic Steatohepatitis Treatment market?

Major trend in this market includes: Pioneering Endogenous Hormones In Non-Alcoholic Steatohepatitis Treatment Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Non-Alcoholic Steatohepatitis Treatment market?

North America was the largest region in the non-alcoholic steatohepatitis treatment market share in 2025. The regions covered in the non-alcoholic steatohepatitis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.